Mirum Pharmaceuticals, Inc.
MIRM
$43.42
-$0.03-0.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 33.28% | 39.65% | 66.72% | 16.10% | 2.12% |
| Total Depreciation and Amortization | 13.96% | 126.65% | 296.00% | 323.64% | 324.23% |
| Total Amortization of Deferred Charges | 4.26% | 3.16% | 32.57% | -- | -- |
| Total Other Non-Cash Items | -33.68% | 3.29% | -74.63% | 0.24% | 108.90% |
| Change in Net Operating Assets | 77.41% | 159.08% | 77.31% | 926.04% | 16.87% |
| Cash from Operations | 69.50% | 121.86% | 78.06% | 181.03% | 51.51% |
| Capital Expenditure | -- | -- | -1,045.59% | 68.29% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 133.05% | -159.52% | -242.13% | -- | -107.41% |
| Cash from Investing | 132.05% | 90.13% | -243.86% | -100.05% | -107.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 159.48% | -98.13% | 247.69% | -92.41% | 21.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 86.13% |
| Cash from Financing | 200.51% | -98.13% | -93.64% | -90.72% | 640.12% |
| Foreign Exchange rate Adjustments | -1,376.85% | 127.94% | -4.39% | -39.89% | 27.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.22% | -273.23% | -146.92% | -22.88% | -115.74% |